Catalyst Wire Dossier Catalyst Wire Dossier

Huperzine A Sustained-Release Tablets

Huperzine A · Shandong Luye Pharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Huperzine A Sustained-Release Tablets, covering 2011-01-25 to 2011-01-25. Get the full timeline:

Most recent: Clinical Trial Update: Study of Huperzine A Sustained-Release Tablets in Patients With Alzheimer's Disease [Phase 2, Phase 3]

See pricing